SVA (Sinovac Biotech, Ltd) Stock Analysis - Politician Trades

Sinovac Biotech, Ltd (SVA) is a publicly traded the market company. As of May 21, 2026, SVA trades at $0.00 with a market cap of $0 and a P/E ratio of 0.00. SVA moved +0.00% today. Year to date, SVA is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces SVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded SVA stock?

Rallies tracks politician and congressional stock disclosures for SVA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

SVA Key Metrics

Key financial metrics for SVA
MetricValue
Price$0.00
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

SVA Analyst Consensus

SVA analyst coverage data. Average price target: $0.00.

Common questions about SVA

Which politicians traded SVA stock?
Rallies tracks politician and congressional stock disclosures for SVA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in SVA?
Yes. Rallies tracks politician and congressional stock disclosures for SVA, including reported purchases, sales, dates, owners, and trade amounts when available.
Is SVA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SVA. It does not provide personalized investment advice.
SVA

SVA